Robertson B, Parker M, Shepherd L, Panieri E, Cairncross L, Malherbe F, Ross I L, Omar F, Hunter A
Department of Radiation Oncology, Cape Town, South Africa.
2Groote Schuur Hospital, Cape Town, South Africa.
Cancers Head Neck. 2018 Nov 19;3:10. doi: 10.1186/s41199-018-0037-5. eCollection 2018.
Information on patients with differentiated thyroid carcinoma in South Africa is limited. The objective of this study was to review demographics and tumour characteristics in a cohort of patients with differentiated thyroid carcinoma, presenting to Groote Schuur Hospital and evaluate risk factors for recurrence and survival.
Retrospective demographic and clinical data were collected on all patients referred between January 2003 and December 2013. Prognostic factors for recurrence free survival and cancer specific survival were assessed using univariate and multivariate analyses.
The total number of patients was 231.The median age at presentation was 44 years and 82% were female patients. The pathological sub-types were papillary (60.6%), follicular (38.9%) and poorly differentiated (0.5%). Total thyroidectomy was performed in 191 patients and 30 patients required neck dissections. A total of 171 (74%) patients received Iodine. The recurrence free and cause specific survival rates at 10 years were 83 and 91%, respectively. Nodal disease at presentation was the only significant risk factor for recurrence ( < 0.001) on multivariate analysis. Significant risk factors for cause specific mortality were age ≥ 45 years ( = 0.006), follicular pathology ( = 0.004), extra-thyroid extension ( = 0.013) and residual tumour ( = 0.004).
Consistent with international trends, patients with differentiated thyroid carcinoma treated at Groote Schuur Hospital had a favourable prognosis. The known risk factors associated with recurrence and survival in this South African cohort were consistent with those reported in developed countries.
南非关于分化型甲状腺癌患者的信息有限。本研究的目的是回顾就诊于格罗特·舒尔医院的分化型甲状腺癌患者队列的人口统计学和肿瘤特征,并评估复发和生存的危险因素。
收集了2003年1月至2013年12月期间所有转诊患者的回顾性人口统计学和临床数据。使用单因素和多因素分析评估无复发生存和癌症特异性生存的预后因素。
患者总数为231例。就诊时的中位年龄为44岁,女性患者占82%。病理亚型为乳头状癌(60.6%)、滤泡状癌(38.9%)和低分化癌(0.5%)。191例患者接受了全甲状腺切除术,30例患者需要行颈部淋巴结清扫术。共有171例(74%)患者接受了碘治疗。10年时的无复发生存率和病因特异性生存率分别为83%和91%。多因素分析显示,就诊时的淋巴结疾病是复发的唯一显著危险因素(<0.001)。病因特异性死亡的显著危险因素为年龄≥45岁(=0.006)、滤泡状病理(=0.004)、甲状腺外侵犯(=0.013)和残留肿瘤(=0.004)。
与国际趋势一致,在格罗特·舒尔医院接受治疗的分化型甲状腺癌患者预后良好。该南非队列中与复发和生存相关的已知危险因素与发达国家报道的一致。